J.W. Burns & Co’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-7,412
| Closed | -$371K | – | 169 |
|
|
2019
Q2 | $371K | Sell |
7,412
-1,382
| -16% | -$69.2K | 0.09% | 131 |
|
|
2019
Q1 | $459K | Sell |
8,794
-152
| -2% | -$7.93K | 0.11% | 115 |
|
|
2018
Q4 | $427K | Sell |
8,946
-400
| -4% | -$19.1K | 0.12% | 116 |
|
|
2018
Q3 | $469K | Sell |
9,346
-268
| -3% | -$13.4K | 0.11% | 123 |
|
|
2018
Q2 | $484K | Sell |
9,614
-1,110
| -10% | -$55.9K | 0.12% | 117 |
|
|
2018
Q1 | $524K | Sell |
10,724
-4,578
| -30% | -$224K | 0.13% | 113 |
|
|
2017
Q4 | $678K | Sell |
15,302
-1,842
| -11% | -$81.6K | 0.17% | 103 |
|
|
2017
Q3 | $870K | Sell |
17,144
-1,701
| -9% | -$86.3K | 0.23% | 93 |
|
|
2017
Q2 | $1.02M | Sell |
18,845
-372
| -2% | -$20.1K | 0.27% | 86 |
|
|
2017
Q1 | $1.01M | Sell |
19,217
-841
| -4% | -$44.3K | 0.28% | 84 |
|
|
2016
Q4 | $966K | Sell |
20,058
-1,838
| -8% | -$88.5K | 0.28% | 82 |
|
|
2016
Q3 | $1.18M | Sell |
21,896
-797
| -4% | -$43K | 0.36% | 73 |
|
|
2016
Q2 | $1.23M | Sell |
22,693
-453
| -2% | -$24.5K | 0.37% | 75 |
|
|
2016
Q1 | $1.17M | Buy |
23,146
+4
| +0% | +$203 | 0.37% | 72 |
|
|
2015
Q4 | $1.17M | Buy |
23,142
+63
| +0.3% | +$3.18K | 0.37% | 74 |
|
|
2015
Q3 | $1.11M | Buy |
23,079
+835
| +4% | +$40.1K | 0.38% | 71 |
|
|
2015
Q2 | $1.16M | Buy |
22,244
+443
| +2% | +$23.1K | 0.38% | 71 |
|
|
2015
Q1 | $1.26M | Buy |
21,801
+2,875
| +15% | +$166K | 0.41% | 66 |
|
|
2014
Q4 | $1.01M | Buy |
18,926
+544
| +3% | +$29.1K | 0.33% | 73 |
|
|
2014
Q3 | $1.06M | Buy |
18,382
+2,124
| +13% | +$122K | 0.36% | 71 |
|
|
2014
Q2 | $1.09M | Buy |
16,258
+1,479
| +10% | +$98.9K | 0.36% | 71 |
|
|
2014
Q1 | $987K | Buy |
14,779
+155
| +1% | +$10.4K | 0.35% | 72 |
|
|
2013
Q4 | $976K | Buy |
14,624
+366
| +3% | +$24.4K | 0.34% | 72 |
|
|
2013
Q3 | $894K | Buy |
14,258
+1,412
| +11% | +$88.5K | 0.34% | 73 |
|
|
2013
Q2 | $802K | Buy |
+12,846
| New | +$802K | 0.33% | 75 |
|